Literature DB >> 19359704

LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.

David F Schaeffer1, Maziar Riazy, Kuljit S Parhar, Johnny H Chen, Vincent Duronio, Tatsuya Sawamura, Urs P Steinbrecher.   

Abstract

Oxidized LDL (oxLDL) promotes lipid accumulation as well as growth and survival signaling in macrophages. OxLDL uptake is mainly due to scavenger receptors SR-AI/II and CD36. However, other scavenger receptors such as lectin-like oxLDL receptor-1 (LOX-1) may also play a role. We used mice with targeted inactivation of the LOX-1 gene to define the role of this receptor in the uptake of oxLDL and in activation of survival pathways. There was no difference in uptake or degradation of 125I-oxLDL in unstimulated macrophages from wild-type and LOX-1 knockout mice and no difference in the rate of clearance of oxLDL from plasma in vivo. However, when expression of LOX-1 was induced with lysophosphatidylcholine, oxLDL uptake and degradation increased 2-fold in wild-type macrophages but did not change in LOX-1 knockout macrophages. Macrophages lacking LOX-1 showed the same stimulation of PKB phosphorylation and enhancement of survival by oxLDL as wild-type cells. These data show that LOX-1 does not alter the uptake of oxLDL in unstimulated macrophages and is not essential for the pro-survival effect of oxLDL in these cells. However, LOX-1 expression is highly inducible by lysophosphatidylcholine and pro-inflammatory cytokines, and if that occurred in macrophages within atheromas, LOX-1 could substantially increase oxLDL uptake by lesion macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359704      PMCID: PMC2724041          DOI: 10.1194/jlr.M900167-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

1.  Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors.

Authors:  D Li; J L Mehta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

2.  TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages.

Authors:  G Draude; R L Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

3.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 4.  Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.

Authors:  David R Greaves; Siamon Gordon
Journal:  J Lipid Res       Date:  2004-11-16       Impact factor: 5.922

5.  Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression.

Authors:  C H Chen; W Jiang; D P Via; S Luo; T R Li; Y T Lee; P D Henry
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

6.  Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.

Authors:  Jawahar L Mehta; Nobuhito Sanada; Chang Ping Hu; Jiawei Chen; Abhijit Dandapat; Fumiaki Sugawara; Hiroo Satoh; Kazuhiko Inoue; Yosuke Kawase; Kou-ichi Jishage; Hiroshi Suzuki; Motohiro Takeya; Laura Schnackenberg; Richard Beger; Paul L Hermonat; Maria Thomas; Tatsuya Sawamura
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

7.  Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.

Authors:  T Aoyama; H Fujiwara; T Masaki; T Sawamura
Journal:  J Mol Cell Cardiol       Date:  1999-12       Impact factor: 5.000

8.  LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells.

Authors:  T Aoyama; M Chen; H Fujiwara; T Masaki; T Sawamura
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

9.  Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

Authors:  P Delerive; C Furman; E Teissier; J Fruchart; P Duriez; B Staels
Journal:  FEBS Lett       Date:  2000-04-07       Impact factor: 4.124

10.  Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels.

Authors:  Rajinder S Hundal; Antonio Gómez-Muñoz; Jennifer Y Kong; Baljinder S Salh; Anthony Marotta; Vincent Duronio; Urs P Steinbrecher
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

View more
  20 in total

Review 1.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 2.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

Review 3.  The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.

Authors:  Jianhui Xie
Journal:  Glycoconj J       Date:  2012-07-12       Impact factor: 2.916

4.  Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.

Authors:  Ekhtear Hossain; Akinobu Ota; Sivasundaram Karnan; Miyuki Takahashi; Shahnewaj B Mannan; Hiroyuki Konishi; Yoshitaka Hosokawa
Journal:  Mol Cell Biochem       Date:  2014-10-28       Impact factor: 3.396

Review 5.  Oxidative Stress in Atherosclerosis.

Authors:  Ajoe John Kattoor; Naga Venkata K Pothineni; Deepak Palagiri; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-09-18       Impact factor: 5.113

Review 6.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

Review 7.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

Review 8.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

Review 9.  Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use.

Authors:  Joaquim Barreto; Sotirios K Karathanasis; Alan Remaley; Andrei C Sposito
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-12       Impact factor: 10.514

10.  Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.

Authors:  Paul Canning; Bridget-Ann Kenny; Vivien Prise; Josephine Glenn; Mosharraf H Sarker; Natalie Hudson; Martin Brandt; Francisco J Lopez; David Gale; Philip J Luthert; Peter Adamson; Patric Turowski; Alan W Stitt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.